In last trading session, DexCom Inc. (NASDAQ:DXCM) saw 9.07 million shares changing hands with its beta currently measuring 1.12. Company’s recent per share price level of $96.35 trading at -$5.2 or -5.12% at ring of the bell on the day assigns it a market valuation of $37.57B. That closing price of DXCM’s stock is at a discount of -44.84% from its 52-week high price of $139.55 and is indicating a premium of 18.07% from its 52-week low price of $78.94. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 4.23 million shares which gives us an average trading volume of 3.46 million if we extend that period to 3-months.
For DexCom Inc. (DXCM), analysts’ consensus is at an average recommendation of a Buy while assigning it a mean rating of 1.50. Splitting up the data highlights that, out of 23 analysts covering the stock, 0 rated the stock as a Sell while 4 recommended an Overweight rating for the stock. 2 suggested the stock as a Hold whereas 17 see the stock as a Buy. 0 analyst(s) advised it as an Underweight. The company is expected to be making an EPS of $0.34 in the current quarter.
In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.
Click here for full details and to join for free
DexCom Inc. (NASDAQ:DXCM) trade information
Upright in the red during last session for losing -5.12%, in the last five days DXCM remained trading in the red while hitting it’s week-highest on Monday, 09/11/23 when the stock touched $96.35 price level, adding 10.86% to its value on the day. DexCom Inc.’s shares saw a change of -14.92% in year-to-date performance and have moved -7.67% in past 5-day. DexCom Inc. (NASDAQ:DXCM) showed a performance of -13.32% in past 30-days. Number of shares sold short was 16.92 million shares which calculate 4.23 days to cover the short interests.
Wall Street analysts have assigned a consensus price target of $146.93 to the stock, which implies a rise of 34.42% to its current value. Analysts have been projecting $130.00 as a low price target for the stock while placing it at a high target of $160.00. It follows that stock’s current price would drop -66.06% in reaching the projected high whereas dropping to the targeted low would mean a loss of -34.92% for stock’s current value.
DexCom Inc. (DXCM) estimates and forecasts
Statistics highlight that DexCom Inc. is scoring comparatively higher than the scores of other players of the relevant industry. The company lost -15.90% of value to its shares in past 6 months, showing an annual growth rate of 41.38% while that of industry is 9.00. Apart from that, the company came raising its revenue forecast for fiscal year 2023. The company is estimating its revenue growth to increase by 21.40% in the current quarter and calculating 11.80% increase in the next quarter. This year revenue growth is estimated to rise 21.70% from the last financial year’s standing.
16 industry analysts have given their estimates about the company’s current quarter revenue by setting an average figure of $938.94 million for the same. And 16 analysts are in estimates of company making revenue of $994.83 million in the next quarter that will end on Dec 2023. Company posted $750.93 million and $815.2 million of sales in current and next quarters respectively a year earlier. Analysts are expecting this quarter sales to grow by 25.00% while estimating it to be 22.00% for the next quarter.
Weighing up company’s earnings over the past 5-year and in the next 5-year periods, we find the company posting an annual earnings growth rate of 37.80% during past 5 years. In 2023, company’s earnings growth rate is likely to be around 57.80% while estimates for its earnings growth in next 5 years are of 36.65%.
DXCM Dividends
DexCom Inc. is more likely to be releasing its next quarterly report between October 25 and October 30 and investors are confident in the company announcing better current-quarter dividends despite the fact that it has been facing issues arising out of mounting debt.
DexCom Inc. (NASDAQ:DXCM)’s Major holders
Insiders are in possession of 0.39% of company’s total shares while institution are holding 100.65 percent of that, with stock having share float percentage of 101.05%. Investors also watch the number of corporate investors in a company very closely, which is 100.65% institutions for DexCom Inc. that are currently holding shares of the company. Vanguard Group Inc is the top institutional holder at DXCM for having 44.28 million shares of worth $4.27 billion. And as of Jun 29, 2023, it was holding 11.42% of the company’s outstanding shares.
The second largest institutional holder is Blackrock Inc., which was holding about 33.25 million shares on Jun 29, 2023. The number of shares represents firm’s hold over 8.57% of outstanding shares, having a total worth of $3.2 billion.
On the other hand, Vanguard Total Stock Market Index Fund and Vanguard 500 Index Fund are the top two Mutual Funds which own company’s shares. As of Jun 29, 2023, the former fund manager was holding 12.1 million shares of worth $1.17 billion or 3.12% of the total outstanding shares. The later fund manager was in possession of 9.23 million shares on Jun 29, 2023, making its stake of worth around $889.25 million in the company or a holder of 2.38% of company’s stock.
- Tags: DexCom Inc., DXCM, DXCM stock, NASDAQ:DXCM
